Retransplantation in heart-lung recipients with obliterative bronchiolitis  by Smith, Julian A. & Wallwork, John
8 1 8 Letters to the Editor 
The Journal of Thoracic and 
Cardiovascular Surgery 
April 1995 
inferior vena cava-pulmonary artery shunt. The authors 
claim to have performed the first bidirectional cavopul- 
monary shunt in 1972. 
In the interest of ethics and accuracy, I must dispute 
their claim. I devised and first performed the procedure in 
i968, and subsequently I published the first results in 
Thorax (1972;27:111-5). 
I appreciate the increased consideration given to bidi- 
rectional cavopulmonary shunt in the recent years. Many 
patients on whom I operated in that initial period are still 
alive and doing satisfactorily with only that procedure. 
Therefore I believe that, in many cases, a mild cyanosis, 
absence of right heart failure, and a single operation are 
preferable to multiple procedures, often accompanied by 
untreatable right heart failure, hepatomegaly, and ascites. 
Gaetano AzzoIina, MD 
Clinica Athena 
San Remo, haly 
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Retransplantation in heart-lung recipients with 
obliterative bronchiolitis 
To the Editor: 
We read with great interest he report by Adams and 
associates in the February 1994 issue of the JOURNAL 
(1994;107:450-9) discussing the results of retransplanta- 
tion procedures (25 heart-lung between 1986 and 1990 
and 9 single lung between 1988 and 1992) in 34 heart-lung 
recipients with obliterative bronchiolitis. Twenty-nine 
(85%) patients were receiving mechanical ventilatory sup- 
port, 31 (91%) required enteral nutrition, and all except 
one were in the hospital before their retransplantation 
procedure. Poor early and long-term results were re- 
ported especially in the group receiving a second heart- 
lung transplant. Similar overall results were found in a 
combined North American-European multicenter series 
of 63 lung retransplantations. 1 
These suboptimal results question the merits of using 
scarce donor organs in patients who would otherwise not 
qualify for a primary heart-lung or lung transplant. The 
need for prolonged ventilatory support (more than 2 or 3 
days) remains a relative contraindication to heart-lung 
and lung transplantation at some centers, including 
ours.2, 3 There is concern about postoperative infection 
owing to the colonization of th e airway during the period 
of mechanical ventilation and also about respiratory mus- 
cle deconditioning during this time. Mechanical ventila- 
tion does not represent a "bridge" to lung transplantation, 
and these patients are in an essentially moribund condi- 
tion. In addition, profound malnutrition and the effect of 
chronic immunosuppression add considerably to the risk 
of this type of operation. Efforts should therefore be 
directed at performing transplantation when the patient is 
in a more optimal preoperative condition. 
We recognize that there are no other therapeutic 
options for patients with end-stage obliterative bronchi- 
olitis after heart-lung transplantation. The allocation of 
another heart-lung block to these patients represents 
inequitable organ allocation especially when up to three 
other patients could benefit from these donor organs. The 
procedure of repeat heart-lung transplantation carries an 
unacceptable early mortality; consumes excessive hospital 
resources including those of the blood bank, and fails to 
deliver an adequate quality of life at long-term follow-up. 
Only three of the 25 patients who underwent a second 
heart-lung transplantation were fully rehabilitated in New 
York Heart Association functional class I at the time of 
this report. 
The results of single lung transplantation i  this group 
are superior to those of repeat heart-lung transplantation. 
The prospects for acceptable long-term survival and reha- 
bilitation appear much better although the reported ex- 
perience is small. We have performed two such proce- 
dures without a successful long-term outcome. We agree 
with the authors that single lung transplantation appears 
to be the preferred surgical option, but we do not believe 
that it represents optimal usage of available donor organs. 
Instead of pursuing retransplantation as the definitive 
treatment of obliterative bronchiolitis after heart-lung or 
lung transplantation, efforts should be directed toward 
prevention of this complication by improving the available 
immunosuppressive agents and also toward new pharma- 
cologic therapies. In the future, pulmonary xenotransplan- 
tation may provide additional donor organs for these 
terminally ill patients. 
Julian A. Smith, MS, FRACS 
John Wallwork, FRCS 
The Transplant Unit 
Papworth Hospital 
Papworth Everard 
Cambridge, CB3 8RE, United Kingdom 
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Aortic and aortic-mitral annular enlargement 
To the Editor: 
The article by Kawachi, Tominaga, and Tokunage a 
refers to two methods, namely, apatch enlargement of the 
aortic root into the anterior leaflet of the mitral valve with 
aortic valve replacement and an enlargement of mitral 
and aortic anuli by patching both rings with double valve 
replacement, both as Manouguian's technique. The epi- 
thet Manouguian's technique is a mistake and needs 
correction. 
The first technique should be called Rastan-Manou- 
guian to give the proper credit to the proper originators. 
The second one must be called Rastan's technique only 
and purely, because it was Dr, H. Rastan who developed 
the concept, tested it, first applied it clinically, and refined 
